Italy Mice Model Market (2025-2030)
The Italy Mice Model Market was valued at $31.5 Million in 2025 and projected to reach to $47.1 Million by 2030, representing a compound annual growth rate of 8.4%. Italy's mice model market is poised for sustained expansion through 2030, driven by increased pharmaceutical R&D spending and strengthened academic research capabilities.
Italy Mice Model Market Trends and Insights
- This 8.4% compound annual growth rate reflects Italy's strengthening position in biomedical research and pharmaceutical development across Europe.
- Italy's investment in life sciences infrastructure and academic research institutions continues to drive demand for preclinical models. The Italian mice model market benefits from robust pharmaceutical R&D activities and increasing collaboration between Italian universities and international biotech firms.
- Italy's regulatory environment and research funding mechanisms support the adoption of advanced animal models in drug discovery and development.
- By 2030, Italy is expected to solidify its role as a key hub for preclinical research in the European mice model sector. Growth in Italy's market is underpinned by rising demand for personalized medicine research and the expansion of contract research organizations (CROs) specializing in preclinical services.
- Italy's commitment to reducing animal testing through refined methodologies while maintaining research quality positions the country favorably within the evolving European regulatory landscape..
Key Market Statistics
- CAGR (2025-2030) 8.4% CAGR
- Market Size, 2025 ~USD 31.5 Million
- Forecast, 2030 ~USD 47.1 Million
- Country Italy
Italy Mice Model Market Overview
Market Valuation Growth :
Italy's mice model market is valued at $31.5 million in 2025, with projections reaching $47.1 million by 2030, representing a robust 8.4% CAGR driven by increased biomedical research investments.
Research Infrastructure Expansion :
Italy's strengthening life sciences infrastructure and world-class academic research institutions are catalyzing demand for advanced mice models in pharmaceutical development and preclinical testing.
European Biomedical Hub :
Italy's strategic position within Europe's biomedical research ecosystem positions it as a key market for mice model suppliers, with growing collaboration between Italian universities and international pharmaceutical companies.
Regulatory and Innovation Support :
Italian government initiatives supporting life sciences innovation and EU regulatory frameworks are encouraging pharmaceutical companies to establish research operations, boosting demand for specialized mice models.
Italy Mice Model Market Dynamics
- The country's commitment to life sciences infrastructure development and its integration within European research networks create favorable conditions for market growth.
- Italian research institutions are increasingly adopting advanced mice models for drug discovery and disease research, supported by EU funding mechanisms and national innovation programs.
- The 8.4% CAGR reflects Italy's growing prominence in biomedical research, with particular strength in oncology, neurology, and immunology research applications.
- Continued investment in research facilities and collaborative partnerships with international pharmaceutical firms will sustain market momentum through the forecast period..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Italy's mice model market is valued at $31.5 million in 2025 and is forecast to reach $47.1 million by 2030, representing an 8.4% CAGR.
- Italy's pharmaceutical and biotech sectors are driving increased demand for preclinical research models and advanced animal testing services.
- Italy's academic institutions and CROs are expanding their capabilities in mice model research, supporting drug discovery and personalized medicine initiatives.
- Italy's regulatory framework emphasizes ethical animal research practices, positioning the country as a responsible leader in European preclinical research.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
Italy Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : Italian and international pharma firms need Italy-specific market data to optimize R&D investments, identify research partnerships, and plan preclinical testing operations in the region.
- Research Institutions : Italian universities and research centers require market insights to benchmark their mice model procurement, identify suppliers, and justify funding requests for biomedical research programs.
- Mice Model Suppliers : Breeding facilities and model providers need Italy market analysis to assess demand, identify growth opportunities, and develop targeted sales strategies for Italian research institutions.
- Contract Research Organizations : CROs operating in Italy need market forecasts and infrastructure data to plan preclinical service expansion and optimize resource allocation for drug development projects.
- Life Sciences Investors : Venture capital and private equity firms evaluating Italian biomedical investments require market-specific growth projections and competitive analysis to support investment decisions.
Key Companies in the Italy Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market-Specific Growth Data : Access Italy-specific valuation metrics, CAGR analysis, and 5-year forecasts to accurately assess market opportunities and competitive positioning within the Italian biomedical research sector.
- Regulatory and Infrastructure Insights : Understand Italy's unique regulatory environment, research institution landscape, and government support mechanisms that directly influence mice model demand and supplier opportunities.
- Competitive Landscape Analysis : Identify key Italian and European suppliers, market consolidation trends, and competitive dynamics specific to Italy's biomedical research ecosystem.
- Strategic Market Entry Planning : Develop targeted go-to-market strategies for Italy with localized insights on pharmaceutical companies, research institutions, and procurement patterns unique to the Italian market.
- Investment Decision Support : Make informed investment and expansion decisions with comprehensive Italy-focused market data, growth drivers, and risk assessments for life sciences ventures.
Frequently asked questions
What is the current size of Italy's mice model market?
Italy's mice model market is valued at $31.5 million in 2025 and is expected to grow to $47.1 million by 2030.
What is the growth rate of Italy's mice model market?
Italy's mice model market is growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.
Which sectors are driving growth in Italy's mice model market?
Italy's pharmaceutical R&D, biotech innovation, academic research institutions, and contract research organizations are the primary drivers of market growth.
How does Italy's mice model market compare to other European countries?
Italy maintains a significant position in Europe's preclinical research landscape, supported by strong academic institutions and regulatory frameworks that emphasize ethical research practices.
What regulatory factors influence Italy's mice model market?
Italy's adherence to EU directives on animal research, emphasis on the 3Rs principle (replacement, reduction, refinement), and investment in alternative methodologies shape market dynamics.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report